Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-6002 in Advanced Parkinson's Disease
NCT00006337Phase 2Completed
- Sponsor
- National Institute of Neurological Disorders and Stroke
- Start
- Oct 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Istradefylline in Parkinson's disease (PD), sponsored by National Institute of Neurological Disorders and Stroke. Started Oct 2000; status: completed.
02
Drugs
Istradefylline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00006337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006337.